Effects of finasteride vs dutasteride on chromogranin A levels in men with benign prostatic hyperplasia

Trial Profile

Effects of finasteride vs dutasteride on chromogranin A levels in men with benign prostatic hyperplasia

Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2011

At a glance

  • Drugs Dutasteride (Primary) ; Finasteride (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 May 2011 Results presented at the 106th Annual Meeting of the American Urological Association.
    • 22 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top